Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy D Blakely

Showing results (141-150 of 224) with videos related to

Pageof 23
Sort By:
Molecular Autism|April 14, 2018
Analysis of neuroanatomical differences in mice with genetically modified serotonin transporters assessed by structural magnetic resonance imagingJacob Ellegood, Yohan Yee, Travis M Kerr, et al.
Nature|April 23, 2011
A transient placental source of serotonin for the fetal forebrainAlexandre Bonnin, Nick Goeden, Kevin Chen, et al.
Neuroscience Letters|May 22, 2020
A social encounter drives gene expression changes linked to neuronal function, brain development, and related disorders in mice expressing the serotonin transporter Ala56 variantKally C O'Reilly, Allison M J Anacker, Tiffany D Rogers, et al.
ACS Chemical Neuroscience|August 9, 2017
Metallo-β-lactamase Domain-Containing Protein 1 (MBLAC1) Is a Specific, High-Affinity Target for the Glutamate Transporter Inducer CeftriaxoneCassandra L Retzlaff, Amanda Kussrow, Tim Schorkopf, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2015
Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporterSean R Bollinger, Darren W Engers, Elizabeth A Ennis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2009
Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypesAna M D Carneiro, David C Airey, Brent Thompson, et al.
Pharmacogenetics and Genomics|March 18, 2011
Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humansUtkarsh Kohli, Maureen K Hahn, Brett A English, et al.
Journal of Neurodevelopmental Disorders|December 5, 2009
Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouseJeremy Veenstra-Vanderweele, Tammy N Jessen, Brent J Thompson, et al.
G3 (Bethesda, Md.)|August 22, 2012
Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysisJ Andrew Hardaway, Shannon L Hardie, Sarah M Whitaker, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 11, 2010
Rab11 supports amphetamine-stimulated norepinephrine transporter traffickingHeinrich J G Matthies, Jessica L Moore, Christine Saunders, et al.
Pageof 23

Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
Molecular Autism|April 14, 2018
Analysis of neuroanatomical differences in mice with genetically modified serotonin transporters assessed by structural magnetic resonance imagingJacob Ellegood, Yohan Yee, Travis M Kerr, et al.
Nature|April 23, 2011
A transient placental source of serotonin for the fetal forebrainAlexandre Bonnin, Nick Goeden, Kevin Chen, et al.
Neuroscience Letters|May 22, 2020
A social encounter drives gene expression changes linked to neuronal function, brain development, and related disorders in mice expressing the serotonin transporter Ala56 variantKally C O'Reilly, Allison M J Anacker, Tiffany D Rogers, et al.
ACS Chemical Neuroscience|August 9, 2017
Metallo-β-lactamase Domain-Containing Protein 1 (MBLAC1) Is a Specific, High-Affinity Target for the Glutamate Transporter Inducer CeftriaxoneCassandra L Retzlaff, Amanda Kussrow, Tim Schorkopf, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2015
Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporterSean R Bollinger, Darren W Engers, Elizabeth A Ennis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2009
Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypesAna M D Carneiro, David C Airey, Brent Thompson, et al.
Pharmacogenetics and Genomics|March 18, 2011
Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humansUtkarsh Kohli, Maureen K Hahn, Brett A English, et al.
Journal of Neurodevelopmental Disorders|December 5, 2009
Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouseJeremy Veenstra-Vanderweele, Tammy N Jessen, Brent J Thompson, et al.
G3 (Bethesda, Md.)|August 22, 2012
Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysisJ Andrew Hardaway, Shannon L Hardie, Sarah M Whitaker, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 11, 2010
Rab11 supports amphetamine-stimulated norepinephrine transporter traffickingHeinrich J G Matthies, Jessica L Moore, Christine Saunders, et al.
Pageof 23